BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22297506)

  • 1. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 2. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC; Hussain SM; Terkivatan T; Zondervan PE; de Man RA
    J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 5. MR imaging of the liver. Cirrhosis and premalignant nodules.
    Ohtomo K
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):331-46. PubMed ID: 9113678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation.
    Krinsky GA; Lee VS; Theise ND
    J Comput Assist Tomogr; 2000; 24(2):189-96. PubMed ID: 10752877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
    Henninger B; Bale R; Schocke M
    Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
    [No Abstract]   [Full Text] [Related]  

  • 10. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 11. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of HCC.
    Ayuso C; Rimola J; GarcĂ­a-Criado A
    Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
    Roncalli M; David E; Gentile A; Pollice L
    Pathologica; 2000 Jun; 92(3):210-20. PubMed ID: 10902435
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications of clinical uses of contrast agents for MR imaging of liver].
    Chen F; Ni YC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):299-300. PubMed ID: 15854502
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
    Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.